Update in respiratory infections 2011.
Pulmonary and Critical Care Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. r-wunderink@northwestern.edu
Richard G
RG
Wunderink
Michael S
MS
Niederman
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D008297:Male; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D011024:Pneumonia, Viral / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D018570:Risk Assessment; D012720:Severity of Illness Index
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents